Glycomics technology promotes early disease screening
Release time:
2025.03.21
At the 2024 Global Medical Congress, "glyco-life clock" technology became a focal topic. Glycomics, as a new generation of early disease screening tools, can accurately predict the risk of chronic diseases such as cardiovascular diseases, diabetes, and neurodegeneration, and is gradually being incorporated into health assessment systems by top global medical institutions.
Recommended News
Share: